Michael Fassbender is swapping his spy‑craft for a monster‑filled nightmare, starring opposite wife Alicia Vikander in the South Korean sci‑fi thriller “Hope.” The film opened in competition at the 79th Cannes Film Festival, earned a seven‑minute standing ovation and has already become the highest‑grossing overseas pre‑sale title for a Korean picture.

Seven‑Minute Ovation Signals Cannes Success for ‘Hope’

“Hope” premiered in the Palme d’Or competition and received a seven‑minute standing ovation, according to the festival’s reports. critics highlighted the film’s blend of creature‑feature thrills and geopolitical tension, noting that the audience’s reaction placed it among the most celebrated entries of the year.

Fassbender’s First Villain Role Since 2017’s ‘Alien: Covenant’

After a hiatus from alien‑centric cinema, Fassbender returns as the primary antagonist, portraying an alien predator alongside Vikander.. The role marks his first on‑screen villainy since Ridley Scott’s “Alien: Covenant” in 2017, a shift that has intrigued fans of his earlier heroic work.

Record‑Breaking Pre‑Sales: Over 200 Territories and Half the Budget Recouped

Industry sources reported that “Hope” secured sales in more than 200 territories,making it the highest‑grossing overseas pre‑sale for any Korean film. International deals have already covered roughly 50 % of the production budget, positioning the movie for strong commercial performance once it lands in U.S. theaters on September 9, via NEON.

Who Will Lead the Sequel if the Alien Threat Returns?

Director Na Hong‑jin disclosed that a sequel concept is ready,but the continuation hinges on the first film’s box‑office results. The open question remains whether Fassbender and Vikander will reprise their alien roles or if the story will pivot to new characters.

Open Question: Will the U.S. Audience Embrace a Korean‑Made Monster Film?

While the Cannes buzz is strong, it is unclear how American viewers will respond to a Korean‑produced sci‑fi thriller led by European actors. the source does not provide early test‑screen data for the U.S. market, leaving the film’s domestic reception an open question.